Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: russet who wrote (850)	5/10/2002 4:17:52 AM
From: Al Collard	Respond to of 1590

Oncolytics Biotech Inc. - Clarification CALGARY, May 9 /CNW/ - In connection with the press release of Oncolytics Biotech Inc. (TSE: ONC, NASDAQ: ONCY) ("Oncolytics") released earlier today, Oncolytics clarifies that effective 12:01 a.m. on May 8, 2002, each SYNSORB Biotech Inc. share represents the right to receive one-eighth of a new SYNSORB share and approximately 0.1008 (not 0.8065 as previously disclosed) of a common share of Oncolytics. For example, an existing SYNSORB shareholder owning 1,000 SYNSORB shares will receive 125 new SYNSORB shares and approximately 100 common shares of Oncolytics.